A novel epigenetic <i>AML1‐ETO/THAP10/miR‐383</i> mini‐circuitry contributes to t(8;21) leukaemogenesis
2017 · EMBO Molecular Medicine · 37 citations
https://doi.org/10.15252/emmm.201607180
J
Jinlong Shi
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
97
Papers
1.5K
Citations
21
h-index
37
i10-index
Jinlong Shi is an academic researcher from Yangtze University. The author has contributed to research in topics: Acute Myeloid Leukemia Research & Myeloproliferative Neoplasms: Diagnosis and Treatment & Hematopoietic Stem Cell Transplantation. The author has an h-index of 21, co-authored 83 publications.
ORCID: 0009-0002-9538-9508Papers by this author
worksHigh expression of ETS2 predicts poor prognosis in acute myeloid leukemia and may guide treatment decisions
2017 · Journal of Translational Medicine · 31 citations
https://doi.org/10.1186/s12967-017-1260-2
High expression of MAP7 predicts adverse prognosis in young patients with cytogenetically normal acute myeloid leukemia
2016 · Scientific Reports · 27 citations
https://doi.org/10.1038/srep34546
High expression of <i><scp>CPNE</scp>3</i> predicts adverse prognosis in acute myeloid leukemia
2017 · Cancer Science · 17 citations
https://doi.org/10.1111/cas.13311
BBB-penetrating magnetoelectric nanoparticles with sustainable Gel formulation for enhanced chemotherapy and reduced postoperative glioma recurrence
2024 · Chemical Engineering Journal · 16 citations
https://doi.org/10.1016/j.cej.2024.154208
Molecular predictors of post-transplant survival in acute myeloid leukemia
2017 · Blood Cancer Journal · 9 citations
https://doi.org/10.1038/s41408-017-0027-6
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat